Organizing Committee

Organizing Committee

Ashok Srivastava, MD, Ph.D., MBA
Ashok Srivastava, MD, Ph.D., MBA

ClinFomatrix Oncology, USA. He is the leader in Cancer Drug Development Worldwide large and complex Phase 3 Clinical Trials. He contributed to 21-INDs and 7-NDAs of Cancer Drugs, acquisition /merger of company and drug for more than $300 million

Bogusław Maciejewski
Bogusław Maciejewski

Dept. Radiotherapy, Cancer Center, M. Skłodowska-Curie Memorial Institute, Branch in Gliwice, Poland

Kedar N. Prasad
Kedar N. Prasad

President of the International Society for Nutrition and Cancer, and Chief Scientific Officer of the Engage Global, USA

Jose Manuel Ordonez
Jose Manuel Ordonez

CCO Therapeutic Area Leader Onco-Haematology, Universidad de Navarra, Spain

Jae Ho Kim
Jae Ho Kim

Professor and Chairman Emeritus, the Henry Ford Health System, USA

Stephen Claude Bondy
Stephen Claude Bondy

Professor in the Center for Occupational & Environmental Health, University of California, USA

Nobuhiro Ohta
Nobuhiro Ohta

National Chiao Tung University, Taiwan

Guy Storme
Guy Storme

Scientific Consulent and board member of the Oncologic Centre, Belgium

Richard Heller
Richard Heller

Prof & Eminent Scholar, Frank Reidy Research Center for Bioelectrics, Old Dominion University, USA

Christianto Benjamin Lumenta
Christianto Benjamin Lumenta

Technical University of Munich, Germany

Change Color